Phase II study of imatinib mesylate for recurrent meningiomas (North American Brain Tumor Consortium study 01-08).
Wen PY, Yung WK, Lamborn KR, Norden AD, Cloughesy TF, Abrey LE, Fine HA, Chang SM, Robins HI, Fink K, Deangelis LM, Mehta M, Di Tomaso E, Drappatz J, Kesari S, Ligon KL, Aldape K, Jain RK, Stiles CD, Egorin MJ, Prados MD.
Wen PY, et al. Among authors: jain rk.
Neuro Oncol. 2009 Dec;11(6):853-60. doi: 10.1215/15228517-2009-010.
Neuro Oncol. 2009.
PMID: 19293394
Free PMC article.
Clinical Trial.